Modified Polyurethane Film Dressing For Skin Graft Donor Sites

The purpose of this study is to determine whether the combination of modified polyurethane film and secondary absorbent dressing for skin graft donor sites avoids the regular uncontrolled leakage, but holds up the advantages of film dressings for this kind of wound.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Wound Healing Infections Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Plastic, Reconstructive, Hand and Burn Surgery, Academic Hospital Munich Bogenhausen, Technical University Munich

Munich, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults over age 18 who require skin grafting

Exclusion criteria

Individuals under the age of 18.

Treatment and study plan

Polyurethane Film

Device

The modified polyurethane film is combined with a secondary absorbent dressing and remained intact until the 10th postoperative day

Primary outcomes

uncontrolled leakage

Time frame: 1-10th day postoperative

Secondary outcomes

pain

Time frame: 1-10th day postoperative
infection

Time frame: 1-10th day postoperative
epithelization status

Time frame: 10th day postoperative

Sponsors and collaborators

Lead sponsor

Klinik Bogenhausen

Other

Registry information

Important dates

Study start: 2007
Primary completion: 2007
Study completion: 2007
First posted: Jan 25, 2008
Registry last updated: Dec 16, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed